PMID- 37168512 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230514 IS - 1936-2625 (Electronic) IS - 1936-2625 (Linking) VI - 16 IP - 4 DP - 2023 TI - Validation of MYC and BCL6 rapid break apart digital fluorescence in situ hybridization assays for clinical use. PG - 76-85 AB - OBJECTIVE: Detection of gene rearrangements in MYC (a family of regulator genes and proto-oncogenes) and human B-cell lymphoma 6 (BCL6) using fluorescence in situ hybridization (FISH) are important in the evaluation of lymphomas, in particular diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma. Our current clinical MYC and BCL6 FISH workflow involves an overnight hybridization of probes with digital analysis using the GenASIs Scan and Analysis instrument (Applied Spectral Imaging). In order to improve assay turnaround time SureFISH probes were validated to reduce the hybridization time from 16 hours down to 1.5 hours. METHODS: Validation was a four-phase process involving initial development of the assays by testing new probes in a manual protocol, and cytogenetic studies to confirm the probe specificity, sensitivity, and localization. In the next phase, the assays were validated as a manual assay. The third phase involved development of the digital FISH assays by testing and optimizing the GenASIs Scan and Analysis instrument. In the final phase, the digital FISH assays were validated. RESULTS: Cytogenetic studies confirmed 100% probe sensitivity/specificity, and localization patterns. Negative reference range cutoffs calculated from 20 normal lymph nodes using the inverse of the beta cumulative probability density function (Excel BETAINV calculation) were 11% inclusive for both manual and digital MYC and BCL6 assays. There was 100% concordance between the manual and digital methods. The shortened hybridization time decreased the overall workflow time by 14.5 hours. CONCLUSIONS: This study validates the use of the SureFISH MYC and BCL6 probes on formalin fixed paraffin embedded (FFPE) tissue sections using a hybridization time of 1.5 hours that shortened the overall workflow by 14.5 hours. The process described also provides a standardized framework for validating digital FISH assays in the future. CI - IJCEP Copyright (c) 2023. FAU - Liew, Michael AU - Liew M AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Rowe, Leslie AU - Rowe L AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Moore, Kristina AU - Moore K AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Aston, Emily AU - Aston E AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - O'Brien, Kathryn AU - O'Brien K AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Longhurst, Maria AU - Longhurst M AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Kenney, Jason AU - Kenney J AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Priest, Marshall AU - Priest M AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Zhou, Wenhua AU - Zhou W AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Wilcock, Diane AU - Wilcock D AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. FAU - Rets, Anton AU - Rets A AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. AD - Department of Pathology, University of Utah School of Medicine Salt Lake City, UT 84132, USA. FAU - Miles, Rodney AU - Miles R AD - ARUP Institute for Clinical and Experimental Pathology(R) Salt Lake, UT 84108, USA. AD - Department of Pathology, University of Utah School of Medicine Salt Lake City, UT 84132, USA. LA - eng PT - Journal Article DEP - 20230415 PL - United States TA - Int J Clin Exp Pathol JT - International journal of clinical and experimental pathology JID - 101480565 PMC - PMC10165167 OTO - NOTNLM OT - GenASIs analysis system OT - digital pathology COIS- None. EDAT- 2023/05/12 01:07 MHDA- 2023/05/12 01:08 PMCR- 2023/04/15 CRDT- 2023/05/11 19:22 PHST- 2022/11/29 00:00 [received] PHST- 2023/03/29 00:00 [accepted] PHST- 2023/05/12 01:08 [medline] PHST- 2023/05/12 01:07 [pubmed] PHST- 2023/05/11 19:22 [entrez] PHST- 2023/04/15 00:00 [pmc-release] PST - epublish SO - Int J Clin Exp Pathol. 2023 Apr 15;16(4):76-85. eCollection 2023.